The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...
Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...
14 小时
News Medical on MSNResearchers identify MLC1 as potential target in multiple sclerosisMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, ...
A brain cancer patient has been left "confused" and "shattered" after learning he took chemotherapy drugs needlessly for more ...
Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as infants, new research shows.
Pregnant MS patients have a higher risk of mental illness during gestation and in the first years after they give birth, researchers reported in a new study published Wednesday in the journal ...
finds evidence that MS patients are less likely to have amyloid plaques, a hallmark of Alzheimer's ... July 4, 2024 — Researchers have discovered several rare types of helper T cells that are ...
cardiff.ac.uk Background: In patients with multiple sclerosis (MS), the natural history of the disease is of considerable importance to predict and understand long-term outcome and inform choices made ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果